Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

In the early days of the semaglutide weight loss wave, many of its users reported less interest in alcohol. A study now says ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

WeightWatchers filed for Chapter 11 bankruptcy in an effort to reduce its debt by more than $1 billion. However, CEO Tara ...

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

Weight loss drugs could “revolutionise the treatment of alcohol use disorder” by “effortlessly” slashing the amount that ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Estimates suggest that around four million people could benefit from weight loss injections. But only 500,000 are thought to be accessing them, either through the NHS or privately. The findings are ...

Ozempic, Wegovy and Mounjaro can still be expensive, but pharmacy-produced GLP-1 compounds are becoming much more affordable.

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial ...